Steven Cohen Eye Point Pharmaceuticals, Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 630,769 shares of EYPT stock, worth $7.31 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
630,769
Previous 630,769
-0.0%
Holding current value
$7.31 Million
Previous $5.49 Million
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding EYPT
# of Institutions
156Shares Held
57.2MCall Options Held
224KPut Options Held
1.41M-
Cormorant Asset Management, LP Boston, MA8.33MShares$96.5 Million5.57% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$60 Million1.88% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$43.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.65MShares$42.3 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.59MShares$41.6 Million0.06% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $395M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...